As well as the point mutations in PAX6 exons, copy number variation should be investigated in the flanking regions of PAX6. We suggest that patients, such as the subjects reported here, should be investigated using high resolution aCGH techniques in a clinical setting if sequencing analyses for PAX6 in patients with aniridia is negative. This evidence concerns the gene PAX6 and aniridia.